table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID 19 outpatients
potential COVID-19 treatments
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
colchicine PRINCIPLE ... COLCORONA
corticosteroids
ciclesonide Clemency Ezer N ...
Immunostimulants drugs
convalescent plasma treatment CONV-ERT C3PO CoV-Early ...
Early convalescent plasma. CoV-Early ...
interferon
peginterferon Feld
neutralizing antibody
bamlanivimab monotherapy BLAZE-1 phase 2 ...
bamlanivimab/etesevimab BLAZE-1 phase 2 ... BLAZE-1 phase 3 ...
casirivimab/imdevimab (Ronapreve) Cov-2067 Weinreich ... Cov-2069 ...
sotrovimab (Xevudy; VIR-7831) COMET-ICE
inhaled corticosteroids
budesonide PRINCIPLE
antiviral and associated therapy
azithromycin ACTION PRINCIPLE Hinks ...
chloroquine and derivatives ALBERTA HOPE-Covid19
hydroxychloroquine COPE – Coalition V COVID-PEP Severity ... BCN PEP-CoV-2-Study 2 ... PATCH Cohort 1 ... Reis ...
fluvoxamine COVID-OUT ... Lenze ... TOGETHER ACTIV-6
hydroxychloroquine plus macrolides
azithromycin plus hydroxychloroquine Rodrigues Q-PROTECT ...
ivermectin ACTIV-6 ... IVERCORCOVID19 ... Chaccour ACTIV 6 ivermectin Buonfrate ... COVID-OUT ... Lopez-Medina TOGETHER ...
lopinavir/ritonavir Reis ...
molnupiravir MOVe-OUT Fischer ...
nirmatrelvir / ritonavir (Paxlovid) EPIC-HR
remdesivir PINETREE ...
sofosbuvir and daclatasvir Roozbeh
Oral antidiabetic drugs
metformin COVID-OUT ...
Renin-angiotensin-system-acting agents
angiotensin receptor blockers (ARBs) University of Minnesota
discontinuation of ACEI/ARB ACEI-COVID ...
Vitamins
vitamin C Thomas ...
zinc plus vitamin c Thomas ...

0 studies excluded by filtering options 0

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons